ImmunoGen misses by $0.01, misses on revenue

• ImmunoGen (NASDAQ:IMGN): FQ2 EPS of -$0.39 misses by $0.01.
• Revenue of $13.85M (-23.2% Y/Y) misses by $4.25M.
• Press Release